LIVSANE Hustenstiller Butamirat, Sirup

7680708910011 CH-70891 Sirup

No image available

Article details

Package size
200
Selling units
200
Measure
ml
Galenic form
Sirup
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
butamirati dihydrogenocitras
1.5 MGML Substance Wirkstoff (Principe actif)
sorbitolum liquidum non cristallisabile
415.1 MGML Substance HBESI
saccharinum natricum
- Substance AIMDK
natrii benzoas
1.1325 MGML Substance HBESI
vanillinum
- Substance AIMDK
acidum hydrochloridum concentratum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrium
0.25 MG Substance HBESI

Authorization holder

Pharmapost AG

4704 Niederbipp

Authorization information

Swissmedic authorization number
70891
Drug name
LIVSANE Hustenstiller Butamirat, Sirup
Galenic form
SIRU
ATC Code
R05DB13
Authorization status
Z
Authorization category
Category C
Dispensing category
D
First authorization
28/07/2026
Authorization expiration date
31/12/9999
IT Number
03.01.2.
Domain
Human medicine
Field of application
Husten, insbesondere trockener Husten

Package details

Description (FR)
LIVSANE Hustenstiller Butamirat sirop
Description (DE)
LIVSANE Hustenstiller Butamirat Sirup
Market launch
01/07/2027
Narcotic (BTM)
No
Buy us a coffee Explore the data